Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of 18 phantom stock units through the Pfizer Supplemental Savings Plan on July 15, 2024.

Summary

• On July 15, 2024, Albert Bourla, Chairman & CEO of Pfizer Inc., acquired 18 phantom stock units.
• The acquisition was made through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of common stock.
• The price of the phantom stock units was $29.1.
• Following the transaction, Bourla directly owns 669,258 shares of common stock.
• These units are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of phantom stock units by the CEO can be seen as a positive sign of his confidence in the company, but it's a routine transaction.

Positives

• The acquisition of phantom stock units by the CEO demonstrates his continued investment in the company's future.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's continued investment in Pfizer through participation in the company's savings plan.

Stakeholder Impact

• The acquisition of phantom stock units by the CEO could have a slightly positive impact on shareholder sentiment.

Key Dates